Implantation of Inferior Vena Cava Interposition Graft in Mouse Model |
| |
Authors: | Yong-Ung Lee Tai Yi Shuhei Tara Avione Y. Lee Narutoshi Hibino Toshiharu Shinoka Christopher K. Breuer |
| |
Affiliation: | 1.Tissue Engineering Program and Surgical Research, Nationwide Children''s Hospital;2.Department of Cardiothoracic Surgery, Nationwide Children''s Hospital;3.Pediatric Surgery, Nationwide Children''s Hospital |
| |
Abstract: | Biodegradable scaffolds seeded with bone marrow mononuclear cells (BMCs) are often used for reconstructive surgery to treat congenital cardiac anomalies. The long-term clinical results showed excellent patency rates, however, with significant incidence of stenosis. To investigate the cellular and molecular mechanisms of vascular neotissue formation and prevent stenosis development in tissue engineered vascular grafts (TEVGs), we developed a mouse model of the graft with approximately 1 mm internal diameter. First, the TEVGs were assembled from biodegradable tubular scaffolds fabricated from a polyglycolic acid nonwoven felt mesh coated with ε-caprolactone and L-lactide copolymer. The scaffolds were then placed in a lyophilizer, vacuumed for 24 hr, and stored in a desiccator until cell seeding. Second, bone marrow was collected from donor mice and mononuclear cells were isolated by density gradient centrifugation. Third, approximately one million cells were seeded on a scaffold and incubated O/N. Finally, the seeded scaffolds were then implanted as infrarenal vena cava interposition grafts in C57BL/6 mice. The implanted grafts demonstrated excellent patency (>90%) without evidence of thromboembolic complications or aneurysmal formation. This murine model will aid us in understanding and quantifying the cellular and molecular mechanisms of neotissue formation in the TEVG. |
| |
Keywords: | Medicine Issue 88 tissue engineering inferior vena cava interposition graft biodegradable tissue engineered vascular graft mouse model |
|
|